• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离子敏感型原位凝胶眼用给药系统的比较。第 1 部分:理化性质考察和体外释放。

Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.

机构信息

Department of Ophthalmology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

出版信息

Int J Pharm. 2011 Jun 15;411(1-2):69-77. doi: 10.1016/j.ijpharm.2011.03.042. Epub 2011 Mar 29.

DOI:10.1016/j.ijpharm.2011.03.042
PMID:21453762
Abstract

Conventional eye drops can result in poor drug bioavailability due to the unique ocular anatomy and physiology. Ion-activated in situ gelling systems are able to crosslink with cations present in the tear fluid, therefore forming a gel on the ocular surface, which results in prolonged corneal contact time. The present study compared a number of anionic polysaccharides (gellan gum, xanthan gum, carrageenan and alginate) to an uncharged (HPMC) and a positively charged (chitosan) polymer system with emphasis on the gelling behaviour, rheological and textural properties, gel microstructure, contact angle and in vitro release characteristics. All systems exhibited physically entangled polymer networks that were able to disentangle upon shear stress and significantly prolonged the in vitro release of a model hydrophilic drug compared to a solution. While systems based on HPMC and chitosan showed no structural changes upon addition of cations, formulations based on gellan gum and carrageenan demonstrated a remarkable increase in viscosity, pseudoplasticity and hardness upon addition of Ca(2+) and K(+) respectively. This renders them favourable for ocular use as they would gel once in contact with the cations of the tear fluid, thus reducing nasolacrimal drainage, but would thin upon shearing, preventing ocular irritation and therefore induced lacrimation.

摘要

由于眼部独特的解剖结构和生理特性,常规眼药水的药物生物利用度较差。离子型原位凝胶系统能够与泪液中的阳离子交联,从而在眼表面形成凝胶,延长角膜接触时间。本研究比较了几种阴离子多糖(结冷胶、黄原胶、卡拉胶和海藻酸钠)与非带电(HPMC)和带正电荷(壳聚糖)聚合物系统,重点研究了凝胶行为、流变学和质构特性、凝胶微观结构、接触角和体外释放特性。所有系统都表现出物理缠结的聚合物网络,在剪切应力下能够解缠,并显著延长模型亲水性药物的体外释放。虽然基于 HPMC 和壳聚糖的系统在添加阳离子后没有结构变化,但基于结冷胶和卡拉胶的制剂在添加 Ca(2+)和 K(+)后分别表现出粘度、假塑性和硬度的显著增加。这使得它们适合眼部使用,因为它们一旦与泪液中的阳离子接触就会形成凝胶,从而减少鼻泪管引流,但在剪切时会变薄,防止眼部刺激和因此引起的流泪。

相似文献

1
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.离子敏感型原位凝胶眼用给药系统的比较。第 1 部分:理化性质考察和体外释放。
Int J Pharm. 2011 Jun 15;411(1-2):69-77. doi: 10.1016/j.ijpharm.2011.03.042. Epub 2011 Mar 29.
2
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.离子敏感型原位凝胶眼用给药系统的比较。第 2 部分:角膜前滞留和体内药效学研究。
Int J Pharm. 2011 Jun 15;411(1-2):78-85. doi: 10.1016/j.ijpharm.2011.03.043. Epub 2011 Mar 29.
3
In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.基于结冷胶和κ-卡拉胶的离子敏感水凝胶通过直接和磁共振成像进行体外和体内眼部安全性及眼表持久性测定。
Eur J Pharm Biopharm. 2015 Aug;94:342-51. doi: 10.1016/j.ejpb.2015.06.003. Epub 2015 Jun 14.
4
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.基于结冷胶和羟乙基纤维素的新型原位凝胶眼用给药系统:创新的流变学特征、体外和体内证据表明具有延长的角膜前滞留时间。
Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6.
5
Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.基于藻酸盐/羟丙基甲基纤维素的加替沙星原位凝胶眼用给药系统的研究
Int J Pharm. 2006 Jun 6;315(1-2):12-7. doi: 10.1016/j.ijpharm.2006.01.029. Epub 2006 Apr 17.
6
A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir.基于κ-卡拉胶的新型离子激活原位凝胶眼用给药系统用于阿昔洛韦。
Drug Dev Ind Pharm. 2018 May;44(5):829-836. doi: 10.1080/03639045.2017.1414232. Epub 2017 Dec 18.
7
Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.采用具有延长滞留时间的 Terminalia arjuna 树胶/藻酸盐原位凝胶系统进行眼部药物输送。
Int J Biol Macromol. 2020 Jun 1;152:1056-1067. doi: 10.1016/j.ijbiomac.2019.10.193. Epub 2019 Nov 18.
8
Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.新型司帕沙星原位凝胶用于眼部药物持续递送的研发与评价:体外和离体表征
Pharm Dev Technol. 2015;20(6):662-9. doi: 10.3109/10837450.2014.910807. Epub 2014 Apr 23.
9
Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.甲磺酸培氟沙星的离子激活型、基于结冷胶的原位眼用凝胶:与传统滴眼液的比较。
Drug Deliv. 2006 May-Jun;13(3):215-9. doi: 10.1080/10717540500309164.
10
Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.壳聚糖基聚电解质复合物与天然多糖在药物传递中的最新进展。
Int J Biol Macromol. 2014 Mar;64:353-67. doi: 10.1016/j.ijbiomac.2013.12.017. Epub 2013 Dec 17.

引用本文的文献

1
Performance and Safety of a Sodium Hyaluronate, Xanthan Gum, and Osmoprotectants Ophthalmic Solution in the Treatment of Dry Eye Disease: An Observational Clinical Investigation.透明质酸钠、黄原胶和渗透保护剂眼药水治疗干眼病的疗效与安全性:一项观察性临床研究。
Ophthalmol Ther. 2025 Apr;14(4):675-692. doi: 10.1007/s40123-025-01099-x. Epub 2025 Feb 21.
2
Ex Vivo Irritation Evaluation of a Novel Brimonidine Nanoemulsion Using the Hen's Egg Test on Chorioallantoic Membrane (HET-CAM).使用鸡胚绒毛尿囊膜试验(HET-CAM)对新型溴莫尼定纳米乳剂进行体外刺激评价
Cureus. 2024 Aug 31;16(8):e68280. doi: 10.7759/cureus.68280. eCollection 2024 Aug.
3
Perspective use of bio-adhesive liquid crystals as ophthalmic drug delivery systems.
生物黏附液晶在眼科药物传递系统中的应用展望。
Sci Rep. 2023 Sep 27;13(1):16188. doi: 10.1038/s41598-023-42185-z.
4
Progress in Ocular Drug Delivery: Challenges and Constraints.眼部药物递送的进展:挑战与限制
Handb Exp Pharmacol. 2024;284:267-288. doi: 10.1007/164_2023_693.
5
In-Situ Thermoresponsive Hydrogel Containing Resveratrol-Loaded Nanoparticles as a Localized Drug Delivery Platform for Dry Eye Disease.含有负载白藜芦醇纳米颗粒的原位热敏水凝胶作为干眼症的局部给药平台
Antioxidants (Basel). 2023 Apr 25;12(5):993. doi: 10.3390/antiox12050993.
6
Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery.用于眼部给药的离子敏感型酒石酸溴莫尼定原位凝胶的制备与表征
Pharmaceuticals (Basel). 2023 Jan 8;16(1):90. doi: 10.3390/ph16010090.
7
Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives.基于纳米和聚合物的刺激响应型药物递送靶向眼微环境的当前进展:综述与未来展望。
Polymers (Basel). 2022 Aug 30;14(17):3580. doi: 10.3390/polym14173580.
8
Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.泊沙康唑眼用纳米混悬剂的基于结冷胶的原位凝胶。
Drug Deliv Transl Res. 2022 Dec;12(12):2920-2935. doi: 10.1007/s13346-022-01155-0. Epub 2022 May 10.
9
A Hydroxypropyl Methylcellulose Film Loaded with AFCP Nanoparticles for Inhibiting Formation of Enamel White Spot Lesions.载有 AFCP 纳米颗粒的羟丙基甲基纤维素膜抑制牙釉质白斑形成。
Int J Nanomedicine. 2021 Nov 16;16:7623-7637. doi: 10.2147/IJN.S335549. eCollection 2021.
10
Gel-Based Materials for Ophthalmic Drug Delivery.用于眼科药物递送的凝胶基材料。
Gels. 2021 Aug 29;7(3):130. doi: 10.3390/gels7030130.